7 hrs ago
Biologic treatments for RA carry similar infection risk
The risk of hospitalized bacterial infections in older rheumatoid arthritis patients is similar for rituximab or abatacept compared to etanercept, although it is higher for infliximab, according to a study published in the July issue of Arthritis Care & Research .
Thu Jul 24, 2014
Infliximab efficacy in rheumatoid arthritis after an inadequate...
Infliximab efficacy in rheumatoid arthritis after an inadequate response to etanercept or adalimumab: results of a target-driven active switch study.
Wed Jul 23, 2014
Mon Jul 21, 2014
The Otago Daily Times
Much interest in stroke treatment
A Dunedin man believed to be the first New Zealander to undergo innovative stroke therapy in the United States may have become a trailblazer.
Wed Jul 16, 2014
Novartis announces NEJM publication of two pivotal Phase III...
Secukinumab met all primary and key secondary endpoints in the ERASURE and FIXTURE studies, including Psoriasis Area and Severity Index 75 and 90 and Investigator's Global Assessment modified 2011 0/1 responses. The results of the studies are the first Phase III data for an IL-17A inhibitor to be published in a major scientific journal and were ... (more)
The New Zealand Herald
Family hoping for miracle after stroke
Luke and Kylee Elliott, with their sons Mason, 4, and Mitchell, 2, have a December appointment in Los Angeles.
Arthritis drug shows potential to stall Alzheimer's
DESPITE decades of work and hundreds of trials, Alzheimer's disease remains an end-of-life trauma for millions.
Applied Clinical Trials
Coherus Announces Initiation Of Phase 3 Trial Of CHS-0214...
This announcement follows the recent initiation of a Phase 3 trial of CHS-0214 in rheumatoid arthritis.
Thu Jul 10, 2014
Positive Results Reported for Psoriasis Drug Secukinumab in Phase III Trials
Positive results from two pivotal phase III studies evaluating the interleukin-17A inhibitor secukinumab have been published online in the New England Journal of Medicine.
Wed Jul 09, 2014
New Psoriasis Drug Shows Promise in Trials
WEDNESDAY July 9, 2014, 2014 -- A new psoriasis drug delivered dramatic results in two clinical trials, perhaps heralding an effective new treatment for patients with the chronic skin disease.
Sat Jul 05, 2014
The Otago Daily Times
Rising to the challenge of a stroke
A stroke doesn't have to mean the end of everything Stroke survivor Dave Griffin and his wife Brenda travelled to Los Angeles for treatment that has given his rehabilitation a big boost.
Thu Jul 03, 2014
Citi Sees Plenty Of Q2 Earnings Beats Ahead In Biotech Sector
Large-cap biotech stocks should see healthy second-quarter results driven by strong demand and new products, a Citi analyst said Thursday.
Wed Jul 02, 2014
El Paso Times
Born to run: 71 year-old competes in USATF Masters Outdoor Championship
"I was having some serious health issues, and my doctor told me the solution was running," Bautista said.
Stroke patient seeks relief in US clinic
Testing time: Grant and Trudy Lawton are travelling to the United States to try a controversial treatment for stroke patients, which they hope will help Trudy lead a more independent and pain-free life.